Ion channels in autoimmune neurodegeneration

FEBS Letters

Volumn 585, Issue 23, 2011, Pages 3836-3842

  Ehling, Petra ^a   Bittner, Stefan ^a   Budde, Thomas ^a   Wiendl, Heinz ^a   Meuth, Sven G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Experimental autoimmune encephalomyelitis; Immune system; Ion channel; Multiple sclerosis; Neuroprotection

Indexed keywords

ACID SENSING ION CHANNEL; ACID SENSING ION CHANNEL 1; ANANDAMIDE; BEPRIDIL; CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; CARBAMAZEPINE; GAMMA INTERFERON; INTERLEUKIN 2; ION CHANNEL; LAMOTRIGINE; NITRENDIPINE; PHENYTOIN; PLACEBO; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TWIK RELATED ACID SENSITIVE POTASSIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CELL MEMBRANE POTENTIAL; CHANNELOPATHY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMYELINATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNOMODULATION; ION CHANNELS; NERVE DEGENERATION; NEURONS; T-LYMPHOCYTES;

ANIMALIA;

EID: 81755179429     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.03.065     Document Type: Review

References (78)

1. C. Kleinschnitz, S.G. Meuth, B.C. Kieseier, and H. Wiendl Immunotherapeutic approaches in MS: update on pathophysiology, emerging agents or strategies 2006 Endocr. Metab. Immune Disord. 7 2007 35 63 (Pubitemid 46388881)
2. M.G. Hanna Genetic neurological channelopathies Nat. Clin. Pract. Neuro. 2 2006 252 263
3. C. Buckley, and A. Vincent Autoimmune channelopathies Nat. Clin. Pract. Neurol. 1 2005 22 33
4. S.G. Waxman Transcriptional channelopathies: an emerging class of disorders Nat. Rev. Neurosci. 2 2001 652 659 (Pubitemid 33675681)
5. S. Bittner TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system Brain 132 2009 2501 2516
6. M.A. Friese, M.J. Craner, R. Etzensperger, S. Vergo, J.A. Wemmie, M.J. Welsh, A. Vincent, and L. Fugger Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system Nat. Med. 13 2007 1483 1489 (Pubitemid 350224241)
7. A.M. Butt, and A. Kalsi Inwardly rectifying potassium channels (Kir) in central nervous system glia: A special role for Kir4.1 in glial functions J. Cell. Mol. Med. 10 2006 33 44 (Pubitemid 44874290)
8. T. Smith, A. Groom, B. Zhu, and L. Turski Autoimmune encephalomyelitis ameliorated by AMPA antagonists Nat. Med. 6 2000 62 66 (Pubitemid 30048527)
9. E.-P. Reich Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice Eur. J. Immunol. 35 2005 1027 1036 (Pubitemid 40542209)
10. S. Bittner Upregulation of K2P5.1 potassium channels in multiple sclerosis Ann. Neurol. 68 2010 58 69
11. J. Douglass, P.B. Osborne, Y.C. Cai, M. Wilkinson, M.J. Christie, and J.P. Adelman Characterization and functional expression of a rat genomic DNA clone encoding a lymphocyte potassium channel J. Immunol. 144 1990 4841 4850 (Pubitemid 20224125)
12. T.E. DeCoursey, K.G. Chandy, S. Gupta, and M.D. Cahalan Voltage-gated K+ channels in human T lymphocytes: A role in mitogenesis? Nature 307 1984 465 468 (Pubitemid 14132063)
13. R.J. Leonard, M.L. Garcia, R.S. Slaughter, and J.P. Reuben Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin Proc. Nat. Acad. Sci. USA 89 1992 10094 10098
14. S. Grissmer, A.N. Nguyen, and M.D. Cahalan Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology J. Gen. Physiol. 102 1993 601 630 (Pubitemid 23328148)
15. S.G. Meuth, S. Bittner, P. Meuth, O.J. Simon, T. Budde, and H. Wiendl TWIK-related Acid-sensitive K+ Channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functions J. Biol. Chem. 283 2008 14559 14570
16. I. Pottosin, E. Bonales-Alatorre, G. Valencia-Cruz, M. Mendoza-Magaña, and O. Dobrovinskaya TRESK-like potassium channels in leukemic T cells Pflügers Archiv. Eur. J. Physiol. 456 2008 1037 1048
17. C. Beeton, and K.G. Chandy Potassium channels, memory T cells, and multiple sclerosis Neuroscientist 11 2005 550 562 (Pubitemid 41611867)
18. C. Beeton Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases Proc. Nat. Acad. Sci. 103 2006 17414 17419 (Pubitemid 44788983)
19. P.A. Koni, R. Khanna, M.C. Chang, M.D. Tang, L.K. Kaczmarek, L.C. Schlichter, and R.A. Flavell Compensatory anion currents in Kv1.3 channel-deficient thymocytes J. Biol. Chem. 278 2003 39443 39451 (Pubitemid 37248500)
20. G.C. Koo Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo J. Immunol. 158 1997 5120 5128 (Pubitemid 127681213)
21. H. Wulff, P.A. Calabresi, R. Allie, S. Yun, M. Pennington, C. Beeton, and K.G. Chandy The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS J. Clin. Invest. 111 2003 1703 1713 (Pubitemid 38057751)
22. H. Rus The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain Proc. Nat. Acad. Sci. USA 102 2005 11094 11099 (Pubitemid 41105998)
23. B. Eichhorn, and D. Dobrev Vascular large conductance calcium-activated potassium channels: functional role and therapeutic potential Naunyn-Schmiedeberg's Arch. Pharmacol. 376 2007 145 155 (Pubitemid 350029414)
24. C. Beeton Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis Proc. Nat. Acad. Sci. USA 98 2001 13942 13947 (Pubitemid 33116003)
25. C.S. Raine, F. Mokhtarian, and D.E. McFarlin Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis Lab. Invest. 51 1984 534 546 (Pubitemid 15175387)
26. A.F. Fomina, C.M. Fanger, J.A. Kozak, and M.D. Cahalan Single channel properties and regulated expression of Ca2+ release-activated Ca2+ (Crac) channels in human T cells J. Cell Biol. 150 2000 1435 1444
27. H.H. Kerschbaum, P.A. Negulescu, and M.D. Cahalan Ion channels, Ca2+ signaling, and reporter gene expression in antigen-specific mouse T cells J. Immunol. 159 1997 1628 1638 (Pubitemid 127484146)
28. M.D. Cahalan, and K.G. Chandy The functional network of ion channels in T lymphocytes Immunol. Rev. 231 2009 59 87
29. C.-A. McCarl Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection J. Immunol. 185 2010 5845 5858
30. J. Ma, C.-A. McCarl, S. Khalil, K. Lüthy, and S. Feske T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells Eur. J. Immunol. 40 2010 3028 3042
31. M.K. Schuhmann Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation J. Immunol. 184 2010 1536 1542
32. C. Picard STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity New England J. Med. 360 2009 1971 1980
33. Q.-H. Liu Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4+ lymphocyte differentiation J. Exp. Med. 196 2002 897 909
34. - thymocytes J. Biol. Chem. 270 1995 22406 22411
35. B. Attali Cloning, functional expression, and regulation of two K+ channels in human T lymphocytes J. Biol. Chem. 267 1992 8650 8657
36. S. Grissmer, B. Dethlefs, J.J. Wasmuth, A.L. Goldin, G.A. Gutman, M.D. Cahalan, and K.G. Chandy Expression and chromosomal localization of a lymphocyte K+ channel gene Proc. Nat. Acad. Sci. USA 87 1990 9411 9415 (Pubitemid 120030636)
37. Z. Varga, T. Csepany, F. Papp, A. Fabian, P. Gogolak, A. Toth, and G. Panyi Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients Immunol. Lett. 124 2009 95 101
38. G. Panyi Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells Proc. Nat. Acad. Sci. USA 101 2004 1285 1290 (Pubitemid 38182681)
39. C. Beeton Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation J. Immunol. 166 2001 936 944 (Pubitemid 32060248)
40. S. Grissmer, R.S. Lewis, and M.D. Cahalan Ca(2+)-activated K+ channels in human leukemic T cells J. Gen. Physiol. 99 1992 63 84
41. M.D. Cahalan, H. Wulff, and K.G. Chandy Molecular properties and physiological roles of ion channels in the immune system J. Clin. Immunol. 21 2001 235 252 (Pubitemid 32652595)
42. M. Partiseti, H. Korn, and D. Choquet Pattern of potassium channel expression in proliferating B lymphocytes depends upon the mode of activation J. Immunol. 151 1993 2462 2470 (Pubitemid 23264499)
43. S.A. Nicolaou, L. Neumeier, Y. Peng, D.C. Devor, and L. Conforti The Ca2+-activated K+ channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytes Am. J. Physiol. Cell Physiol. 292 2007 C1431 C1439
44. M.I. Lioudyno Orai1 and STIM1 move to the immunological synapse and are up-regulated during T cell activation Proc. Nat. Acad. Sci. 105 2008 2011 2016 (Pubitemid 351439456)
45. T. Jayaraman, E. Ondriasova, K. Ondrias, D.J. Harnick, and A.R. Marks The inositol 1, 4, 5-trisphosphate receptor is essential for T-cell receptor signaling Proc. Nat. Acad. Sci. USA 92 1995 6007 6011
46. T. Sugiyama, M. Yamamoto-Hino, A. Miyawaki, T. Furuichi, K. Mikoshiba, and M. Hasegawa Subtypes of inositol 1,4,5-trisphosphate receptor in human hematopoietic cell lines: dynamic aspects of their cell-type specific expression FEBS Lett. 349 1994 191 196
47. M. Cahalan, and R. Lewis Role of potassium and chloride channels in volume regulation by T lymphocytes Soc. Gen. Physiol. Ser. 43 1988 281 301
48. R.S. Lewis, P.E. Ross, and M.D. Cahalan Chloride channels activated by osmotic stress in T lymphocytes J. Gen. Physiol. 101 1993 801 826 (Pubitemid 23175827)
49. Z.-F. Lai, Y.-Z. Chen, Y. Nishimura, and K. Nishi An amiloride-sensitive and voltage-dependent Na+ channel in an HLA-DR-restricted human T cell clone J. Immunol. 165 2000 83 90 (Pubitemid 30429493)
50. E. Ottaviani, A. Franchini, M. Mandrioli, A. Saxena, A. Hanukoglu, and I. Hanukoglu Amiloride-sensitive epithelial sodium channel subunits are expressed in human and mussel immunocytes Dev. Comp. Immunol. 26 2002 395 402 (Pubitemid 34213769)
51. J.A. Black, S.G. Waxman, and K.J. Smith Remyelination of dorsal column axons by endogenous Schwann cells restores the normal pattern of Nav1.6 and Kv1.2 at nodes of Ranvier Brain 129 2006 1319 1329
52. J.A. Black, S. Liu, M. Carrithers, L.M. Carrithers, and S.G. Waxman Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine Ann. Neurol. 62 2007 21 33 (Pubitemid 47235277)
53. R. Kapoor Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: A randomised, double-blind, placebo-controlled, parallel-group trial Lancet Neurol. 9 2010 681 688
54. S.G. Waxman Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis - current status Nat. Clin. Pract. Neurol. 4 2008 159 169 (Pubitemid 351356596)
55. S.G. Meuth, S. Bittner, J.C. Ulzheimer, C. Kleinschnitz, B.C. Kieseier, and H. Wiendl Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies BioDrugs 24 2010 249
56. B. Kornek Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions Am. J. Pathol. 157 2000 267 276 (Pubitemid 30641742)
57. H.-N. Liu, E. Molina-Holgado, and G. Almazan Glutamate-stimulated production of inositol phosphates is mediated by Ca2+ influx in oligodendrocyte progenitors Eur. J. Pharmacol. 338 1997 277 287 (Pubitemid 27507771)
58. A.M. Brown, R.E. Westenbroek, W.A. Catterall, and B.R. Ransom Axonal L-Type Ca2+ channels and anoxic injury in rat CNS white matter J. Neurophysiol. 85 2001 900 911 (Pubitemid 32147788)
59. E. Brand-Schieber, and P. Werner Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis Exp. Neurol. 189 2004 5 9 (Pubitemid 39024449)
60. R. Nashmi, and M.G. Fehlings Mechanisms of axonal dysfunction after spinal cord injury: with an emphasis on the role of voltage-gated potassium channels Brain Res. Rev. 38 2001 165 191 (Pubitemid 34066501)
61. S.P. Yu Regulation and critical role of potassium homeostasis in apoptosis Prog. Neurobiol. 70 2003 363 386 (Pubitemid 37101137)
62. E. Beraud Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy Ann. Neurol. 60 2006 586 596 (Pubitemid 44871801)
63. J. Booss, M.M. Esiri, W.W. Tourtellotte, and D.Y. Mason Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis J. Neurol. Sci. 62 1983 219 232 (Pubitemid 14176251)
64. H.F. McFarland, and R. Martin Multiple sclerosis: A complicated picture of autoimmunity Nat. Immunol. 8 2007 913 919 (Pubitemid 47300005)
65. S. Vergo, M.J. Craner, R. Etzensperger, K. Attfield, M.A. Friese, J. Newcombe, M. Esiri, and L. Fugger Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model Brain 134 2011 571 584
66. M.E. Hartness, A. Lewis, G.J. Searle, I. O'Kelly, C. Peers, and P.J. Kemp Combined antisense and pharmacological approaches implicate hTASK as an airway O2 sensing K+ channel J. Biol. Chem. 276 2001 26499 26508
67. A. Lewis, M.E. Hartness, C.G. Chapman, I.M. Fearon, H.J. Meadows, C. Peers, and P.J. Kemp Recombinant hTASK1 is an O2-Sensitive K+ Channel Biochem. Biophys. Res. Commun. 285 2001 1290 1294
68. S. Rajan, E. Wischmeyer, G. Xin Liu, R. Preisig-Müller, J. Daut, A. Karschin, and C. Derst TASK-3, a novel tandem pore domain acid-sensitive K+channel J. Biol. Chem. 275 2000 16650 16657
69. S.G. Meuth, T. Budde, T. Kanyshkova, T. Broicher, T. Munsch, and H.-C. Pape Contribution of TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons J. Neurosci. 23 2003 6460 6469 (Pubitemid 36909871)
70. S.P. Yu, and D.W. Choi Ions, cell volume, and apoptosis Proc. Nat. Acad. Sci. USA 97 2000 9360 9362 (Pubitemid 30650778)
71. D. Baker Endocannabinoids control spasticity in a multiple sclerosis model The FASEB J. 15 2001 300 302
72. V. Brinkmann, A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, and P. Burtin Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat. Rev. Drug Discov. 9 2010 883 897
73. D. Bates Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials Neurology 76 2011 S14 S25
74. M.S. Freedman Long-term follow-up of clinical trials of multiple sclerosis therapies Neurology 76 2011 S26 S34
75. M. Buttmann, and H. Wiendl Therapeutische monoklonale Antikörper in Der Neurologie Der. Nervenarzt. 81 2010 753 766
76. J.P. Overington, B. Al-Lazikani, and A.L. Hopkins How many drug targets are there? Nat. Rev. Drug Discov. 5 2006 993 996 (Pubitemid 44835126)
77. P. Imming, C. Sinning, and A. Meyer Drugs, their targets and the nature and number of drug targets Nat. Rev. Drug Discov. 5 2006 821 834 (Pubitemid 44480536)
78. S. Rangaraju, V. Chi, M.W. Pennington, and K.G. Chandy Kv1.3 potassium channels as a therapeutic target in multiple sclerosis Expert Opin. Therap. Targets 13 2009 909 924